Literature DB >> 18445459

Survey of European programmes for the epidemiological surveillance of congenital toxoplasmosis.

A Bénard1, E Petersen, R Salamon, G Chêne, R Gilbert, L R Salmi.   

Abstract

The objective of this investigation was to describe systems for the epidemiological surveillance of congenital toxoplasmosis implemented in European countries. In September 2004, a questionnaire, adapted from the evaluation criteria published by the United States Centers for Disease Control and Prevention, was sent to a panel of national correspondents in 35 countries in the European geographical area with knowledge of the epidemiological surveillance systems implemented in their countries. Where necessary, we updated the information until July 2007. Responses were received from 28 countries. Some 16 countries reported routine surveillance for toxoplasmosis. In 12 countries (Bulgaria, Cyprus, Czech Republic, England and Wales, Estonia, Ireland, Latvia, Lithuania, Malta, Poland, Scotland and Slovakia), surveillance was designed to detect only symptomatic toxoplasmosis, whether congenital or not. Four countries reported surveillance of congenital toxoplasmosis, on a regional basis in Italy and on a national basis in Denmark, France and Germany. In conclusion, epidemiological surveillance of congenital toxoplasmosis needs to be improved in order to determine the true burden of disease and to assess the effectiveness of and the need for existing prevention programmes.

Entities:  

Mesh:

Year:  2008        PMID: 18445459      PMCID: PMC2740836          DOI: 10.2807/ese.13.15.18834-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  12 in total

1.  [Screening and early detection in blood transfusion: when are they indicated?].

Authors:  L R Salmi; S Mathoulin; P Perez; S Lawson-Ayayi
Journal:  Transfus Clin Biol       Date:  1997-07       Impact factor: 1.406

2.  The reporting of communicable diseases.

Authors:  R Marier
Journal:  Am J Epidemiol       Date:  1977-06       Impact factor: 4.897

3.  Guidelines for evaluating surveillance systems.

Authors: 
Journal:  MMWR Suppl       Date:  1988-05-06

4.  Comparison of an active and passive surveillance system of primary care providers for hepatitis, measles, rubella, and salmonellosis in Vermont.

Authors:  R L Vogt; D LaRue; D N Klaucke; D A Jillson
Journal:  Am J Public Health       Date:  1983-07       Impact factor: 9.308

5.  The national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999-2002.

Authors:  D R Schmidt; B Hogh; O Andersen; J Fuchs; H Fledelius; E Petersen
Journal:  Arch Dis Child       Date:  2006-08       Impact factor: 3.791

Review 6.  Cutaneous manifestations of toxoplasmosis.

Authors:  S D Mawhorter; D Effron; R Blinkhorn; P J Spagnuolo
Journal:  Clin Infect Dis       Date:  1992-05       Impact factor: 9.079

Review 7.  Toxoplasmosis.

Authors:  J G Montoya; O Liesenfeld
Journal:  Lancet       Date:  2004-06-12       Impact factor: 79.321

8.  Symptomatic toxoplasma infection due to congenital and postnatally acquired infection.

Authors:  R Gilbert; H K Tan; S Cliffe; E Guy; M Stanford
Journal:  Arch Dis Child       Date:  2006-03-17       Impact factor: 3.791

9.  Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial.

Authors:  J McAuley; K M Boyer; D Patel; M Mets; C Swisher; N Roizen; C Wolters; L Stein; M Stein; W Schey
Journal:  Clin Infect Dis       Date:  1994-01       Impact factor: 9.079

10.  Prognostic factors for the long-term development of ocular lesions in 327 children with congenital toxoplasmosis.

Authors:  C Binquet; M Wallon; C Quantin; L Kodjikian; J Garweg; J Fleury; F Peyron; M Abrahamowicz
Journal:  Epidemiol Infect       Date:  2003-12       Impact factor: 2.451

View more
  20 in total

1.  Comparison of mother and child antibodies that target high-molecular-mass Toxoplasma gondii antigens by immunoblotting improves neonatal diagnosis of congenital toxoplasmosis.

Authors:  Coralie L'Ollivier; Martine Wallon; Benoit Faucher; Renaud Piarroux; François Peyron; Jacqueline Franck
Journal:  Clin Vaccine Immunol       Date:  2012-06-13

2.  Seroprevalence of Toxoplasma gondii antibodies in the Slovak Republic.

Authors:  J Strhársky; C Klement; F Hrubá
Journal:  Folia Microbiol (Praha)       Date:  2010-02-07       Impact factor: 2.099

3.  Investigation and management of Toxoplasma gondii infection in pregnancy and infancy: a prospective study.

Authors:  Paola di Carlo; Amelia Romano; Alessandra Casuccio; Salvatore Cillino; Maria Gabriella Schimmenti; Giorgio Mancuso; Stella la Chiusa; Vincenzo Novara; Daniela Ingrassia; Valentina Li Vecchi; Marcello Trizzino; Lucina Titone
Journal:  Acta Pharmacol Sin       Date:  2011-07-11       Impact factor: 6.150

4.  Seroprevalence for toxoplasmosis in individuals living in north west Tuscany: access to Toxo-test in central Italy.

Authors:  B Pinto; B Castagna; R Mattei; R Bruzzi; L Chiumiento; R Cristofani; W Buffolano; F Bruschi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-02       Impact factor: 3.267

5.  Congenital toxoplasmosis--a report on the Danish neonatal screening programme 1999-2007.

Authors:  Dennis Röser; Henrik Vedel Nielsen; Eskild Petersen; Peter Saugmann-Jensen; Bent Nørgaard-Pedersen; Peter Bent Nørgaard-Pedersen
Journal:  J Inherit Metab Dis       Date:  2010-06-29       Impact factor: 4.982

6.  "Blind periods" in screening for toxoplasmosis in pregnancy in Austria - a debate.

Authors:  Ulrich Sagel; Alexander Krämer; Rafael T Mikolajczyk
Journal:  BMC Infect Dis       Date:  2012-05-16       Impact factor: 3.090

7.  Incidence of maternal Toxoplasma infections in pregnancy in Upper Austria, 2000-2007.

Authors:  Ulrich Sagel; Alexander Krämer; Rafael T Mikolajczyk
Journal:  BMC Infect Dis       Date:  2011-12-14       Impact factor: 3.090

8.  Toxoplasma gondii infection in Kyrgyzstan: seroprevalence, risk factor analysis, and estimate of congenital and AIDS-related toxoplasmosis.

Authors:  Gulnara Minbaeva; Alexander Schweiger; Aigerim Bodosheva; Omurbek Kuttubaev; Adrian B Hehl; Isabelle Tanner; Iskender Ziadinov; Paul R Torgerson; Peter Deplazes
Journal:  PLoS Negl Trop Dis       Date:  2013-02-07

9.  A dedicated surveillance network for congenital toxoplasmosis in Greece, 2006-2009: assessment of the results.

Authors:  Maria Aptouramani; Maria Theodoridou; George Syrogiannopoulos; Andreas Mentis; Vasiliki Papaevangelou; Katerina Gaitana; Alexandros Daponte; Christos Hadjichristodoulou
Journal:  BMC Public Health       Date:  2012-11-22       Impact factor: 3.295

10.  Toxoplasma infection in individuals in central Italy: does a gender-linked risk exist?

Authors:  B Pinto; R Mattei; G A Moscato; M Cristofano; M Giraldi; R Scarpato; W Buffolano; F Bruschi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.